Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al.
Blood.
2020;
26:S138-S138.
The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1).
Kellner, ES; Rathbun, PA; Marshall, GS; Tolusso, LK; Smolarek, TA; Sun, M; Chandra, S; Bleesing, J; Marsh, RA.
Journal of Clinical Immunology.
2019;
39:857-859.
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
Marsh, RA; Leiding, JW; Logan, BR; Griffith, LM; Arnold, DE; Haddad, E; Falcone, EL; Yin, Z; Patel, K; Arbuckle, E; et al.
Journal of Clinical Immunology.
2019;
39:653-667.
Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH.
Chiang, SC C; Bleesing, JJ; Marsh, RA.
Frontiers in Immunology.
2019;
10.
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.
Farmer, JR; Foldvari, Z; Ujhazi, B; De Ravin, SS; Chen, K; Bleesing, JJ H; Schuetz, C; Al-Herz, W; Abraham, RS; Joshi, AY; et al.
Journal of Allergy and Clinical Immunology-In Practice.
2019;
7:1970-1985.e4.
Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening.
Purswani, P; Meehan, CA; Kuehn, HS; Chang, Y; Dasso, JF; Meyer, AK; Ujhazi, B; Csomos, K; Lindsay, D; Alberdi, T; et al.
Frontiers in Pediatrics.
2019;
7.
Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.
Dimitrova, D; Rose, JJ; Uzel, G; Cohen, JI; Rao, KV; Bleesing, JH; Kanakry, CG; Kanakry, JA.
Journal of Clinical Immunology.
2019;
39:1-3.
Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4(+) T-cell development and allergic airway disease.
Patterson, AR; Bolcas, P; Lampe, K; Cantrell, R; Ruff, B; Lewkowich, I; Hogan, SP; Janssen, EM; Bleesing, J; Hershey, GK K; et al.
Journal of Allergy and Clinical Immunology.
2019;
143:245-257.e6.
Gimap5-dependent inactivation of GSK3 beta is required for CD4(+) T cell homeostasis and prevention of immune pathology.
Patterson, AR; Endale, M; Lampe, K; Aksoylar, HI; Flagg, A; Woodgett, JR; Hildeman, D; Jordan, MB; Singh, H; Kucuk, Z; et al.
Nature Communications.
2018;
9.
Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.
Shamriz, O; Patel, K; Marsh, RA; Bleesing, J; Joshi, AY; Lucas, L; Prince, C; Pencheva, BB; Kobrynski, L; Chandrakasan, S.
Clinical Immunology.
2018;
197:219-223.